1. Sarrett JC. Biocertification and neurodiversity: the role and implications of self-diagnosis in autistic communities. Neuroethics. 2016; 9(1):23–36.
Article
2. Oakley B, Tillmann J, Ruigrok A, Baranger A, Takow C, Charman T, et al. COVID-19 health and social care access for autistic people: European policy review. BMJ Open. 2021; 11(6):e045341.
Article
3. Simmons AL. COVID-19 social distancing: a snippet view of the autistic social world. Disabil Soc. 2020; 35(6):1007–1011.
Article
9. Choi MJ, Choi WS, Seong H, Choi JY, Kim JH, Kim YJ, et al. Developing a framework for pandemic COVID-19 vaccine allocation: a modified Delphi consensus study in Korea. J Korean Med Sci. 2021; 36(23):e166. PMID:
34128597.
Article
10. Jung J. Preparing for the coronavirus disease (COVID-19) vaccination: evidence, plans, and implications. J Korean Med Sci. 2021; 36(7):e59. PMID:
33619920.
Article
12. Korea Federation of Organization of the Disabled. The vaccination plan for priority on to people with disabilities, and workers in the disability organisation, which is vulnerable to COVID-19 are still lacking. 2021. 5. 03. Updated 2021. Accessed July 21, 2021.
http://www.kofod.or.kr/bbs/sub2_2/89984.
14. Choi JW, Han E, Lee SG, Shin J, Kim TH. Risk of COVID-19 and major adverse clinical outcomes among people with disabilities in South Korea. Disabil Health J. 2021; 14(4):101127. PMID:
34134944.
Article
16. Karpur A, Vasudevan V, Shih A, Frazier T. Brief report: impact of COVID-19 in individuals with autism spectrum disorders: analysis of a National Private Claims Insurance database. J Autism Dev Disord. Forthcoming. 2021.
Article
17. Courtenay K, Cooper V. Covid 19: people with learning disabilities are highly vulnerable. BMJ. 2021; 374:n1701. PMID:
34261641.
Article
18. Hotez E, Hotez PJ, Rosenau KA, Kuo AA. Prioritising COVID-19 vaccinations for individuals with intellectual and developmental disabilities. EClinicalMedicine. 2021; 32:100749. PMID:
33585807.
19. Lima ME, Barros LC, Aragão GF. Could autism spectrum disorders be a risk factor for COVID-19? Med Hypotheses. 2020; 144:109899. PMID:
32505067.
Article
20. Kim MA, Yi J, Sung J, Hwang S, Howey W, Jung SM. Changes in life experiences of adults with intellectual disabilities in the COVID-19 pandemics in South Korea. Disabil Health J. Forthcoming. 2021.
Article
21. Sakamoto S, Miyawaki D, Goto A, Harima Y, Tokuhara D, Inoue K. COVID-19 phobia in a boy with undiagnosed autism spectrum disorder: a case report. Medicine (Baltimore). 2021; 100(22):e26233. PMID:
34087907.
Article
23. Narzisi A. Handle the autism spectrum condition during coronavirus (COVID-19) stay at home period: ten tips for helping parents and caregivers of young children. Brain Sci. 2020; 10(4):207.
Article
25. Aaronson B, Glick SN, Kirk CJ, McCloud WA 4th, Sasser TR, Zerr DM, et al. Assessment of feasibility of face covering in school-aged children with autism spectrum disorders and attention-deficit/hyperactivity disorder. JAMA Netw Open. 2021; 4(5):e2110281. PMID:
33999167.
Article
26. Sarah AC, Nicolaidis C, Davies B, Des Roches Rosa S, Eisenman D, Onaiwu MG, et al. An expert discussion on autism in the COVID-19 pandemic. Autism in Adulthood. 2020; 2(2):106–117.
Article
28. Crompton CJ, DeBrabander K, Heasman B, Milton D, Sasson NJ. Double empathy: why autistic people are often misunderstood. Front Young Minds. 2021; 9:554875.
Article
29. Milton DE. On the ontological status of autism: the ‘double empathy problem’. Disabil Soc. 2012; 27(6):883–887.
Article
32. Lee SB, Kim JB. A country report: impact of COVID-19 and inequity of health on South Korea's disabled community during a pandemic. Disabil Soc. 2020; 35(9):1514–1519.
Article